Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💻 Telehealth

Location

India

Market Cap

USD 12.72 B

Share Price

USD 37.58

Avg Daily Volume

343,112

Change (1 day)

-0.14%

Change (1 year)

8.67%

Change (YTD)

-4.26%

Torrent Pharmaceuticals Limited Price to Sales Ratio (P/S) on June 18, 2025: 9.44

Torrent Pharmaceuticals Limited Price to Sales Ratio (P/S) is 9.44 on June 18, 2025, a 2.64% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Torrent Pharmaceuticals Limited 52-week low Price to Sales Ratio (P/S) is 11.26 on June 18, 2025, which is 19.36% above the current Price to Sales Ratio (P/S).
Torrent Pharmaceuticals Limited 52-week low Price to Sales Ratio (P/S) is 8.83 on June 18, 2025, which is -6.48% below the current Price to Sales Ratio (P/S).
Torrent Pharmaceuticals Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 10.03.

Daily

From:

To:

Zoom:

Key data

Date	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield

NSE: TORNTPHARM.NS

Torrent Pharmaceuticals Limited

CEO	Mr. Sanjay Gupta
IPO Date	July 1, 2002
Location	India
Headquarters	Torrent House
Employees	15,718
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 💻 Telehealth

Description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.